{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:20:20Z","timestamp":1790083220134,"version":"4.0.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Provincial Science and Technology Special Fund of Guangdong in 2021","award":["No. 2021-88-53"],"award-info":[{"award-number":["No. 2021-88-53"]}]},{"name":"Provincial Science and Technology Special Fund of Guangdong in 2022","award":["No. 2022-124-6"],"award-info":[{"award-number":["No. 2022-124-6"]}]},{"name":"Fund from National Health Commission Medical and Health Science and Technology Development and Research Center","award":["No. WKZX2022JG0138"],"award-info":[{"award-number":["No. WKZX2022JG0138"]}]},{"name":"Innovation Team Project of Guangdong Universities, China","award":["Natural, No. 2024KCXTD019"],"award-info":[{"award-number":["Natural, No. 2024KCXTD019"]}]},{"name":"Grant for Key Disciplinary Project of Clinical Medicine under the High-level University Development Program, Guangdong, China","award":["No. 2024-2025"],"award-info":[{"award-number":["No. 2024-2025"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03243-8","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:35:06Z","timestamp":1781249706000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Growth differentiation factor-15 and the incidence, bidirectional progression, and risk prediction of atherosclerotic cardiovascular disease and metabolic dysfunction-associated steatotic liver disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0\u20133"],"prefix":"10.1186","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1644-1867","authenticated-orcid":false,"given":"Xiaojing","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4346-7159","authenticated-orcid":false,"given":"Haoxian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1941-0120","authenticated-orcid":false,"given":"Zhuokai","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3462-6902","authenticated-orcid":false,"given":"Xueying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3688-072X","authenticated-orcid":false,"given":"Cuihong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4977-259X","authenticated-orcid":false,"given":"Nan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4104-2402","authenticated-orcid":false,"given":"Jingtao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3306-1717","authenticated-orcid":false,"given":"Hanyuan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4561-4172","authenticated-orcid":false,"given":"Xuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6399-154X","authenticated-orcid":false,"given":"Qinglong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6135-0790","authenticated-orcid":false,"given":"Kunyao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0489-6643","authenticated-orcid":false,"given":"Pan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8131-8622","authenticated-orcid":false,"given":"Xianghui","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6446-9344","authenticated-orcid":false,"given":"Liwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7444-3615","authenticated-orcid":false,"given":"Wenfeng","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4634-6901","authenticated-orcid":false,"given":"Wenqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youti","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4489-9498","authenticated-orcid":false,"given":"Xuerui","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5574-0048","authenticated-orcid":false,"given":"Jiabao","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-6425-3847","authenticated-orcid":false,"given":"Yequn","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"key":"3243_CR1","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","volume":"148","author":"CE Ndumele","year":"2023","unstructured":"Ndumele CE, Rangaswami J, Chow SL, Neeland IJ, Tuttle KR, Khan SS, et al. Cardiovascular-Kidney-Metabolic health: a Presidential Advisory from the American Heart Association. Circulation. 2023;148:1606\u201335. https:\/\/doi.org\/10.1161\/CIR.0000000000001184.","journal-title":"Circulation"},{"key":"3243_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","volume":"149","author":"SS Khan","year":"2024","unstructured":"Khan SS, Matsushita K, Sang Y, Ballew SH, Grams ME, Surapaneni A, et al. Development and validation of the American Heart Association\u2019s PREVENT equations. Circulation. 2024;149:430\u201349. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.123.067626.","journal-title":"Circulation"},{"key":"3243_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahjo.2021.100046","volume":"9","author":"AM di Candia","year":"2021","unstructured":"di Candia AM, de Avila DX, Moreira GR, Villacorta H, Maisel AS. Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: potential role in cardiovascular diseases. Am Heart J Plus Cardiol Res Pract. 2021;9:100046. https:\/\/doi.org\/10.1016\/j.ahjo.2021.100046.","journal-title":"Am Heart J Plus Cardiol Res Pract"},{"key":"3243_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.ejim.2021.02.011","volume":"88","author":"S Nopp","year":"2021","unstructured":"Nopp S, K\u00f6nigsbr\u00fcgge O, Kraemmer D, Pabinger I, Ay C. Growth differentiation factor-15 predicts major adverse cardiac events and all-cause mortality in patients with atrial fibrillation. Eur J Intern Med. 2021;88:35\u201342. https:\/\/doi.org\/10.1016\/j.ejim.2021.02.011.","journal-title":"Eur J Intern Med"},{"key":"3243_CR5","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1007\/s40620-021-01020-2","volume":"34","author":"MV Perez-Gomez","year":"2021","unstructured":"Perez-Gomez MV, Pizarro-Sanchez S, Gracia-Iguacel C, Cano S, Cannata-Ortiz P, Sanchez-Rodriguez J, et al. Urinary Growth Differentiation Factor-15 (GDF15) levels as a biomarker of adverse outcomes and biopsy findings in chronic kidney disease. J Nephrol. 2021;34:1819\u201332. https:\/\/doi.org\/10.1007\/s40620-021-01020-2.","journal-title":"J Nephrol"},{"key":"3243_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-020-01020-9","volume":"19","author":"X He","year":"2020","unstructured":"He X, Su J, Ma X, Lu W, Zhu W, Wang Y, et al. The association between serum growth differentiation factor 15 levels and lower extremity atherosclerotic disease is independent of body mass index in type 2 diabetes. Cardiovasc Diabetol. 2020;19:40. https:\/\/doi.org\/10.1186\/s12933-020-01020-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/hepr.14148","volume":"55","author":"MP Werge","year":"2025","unstructured":"Werge MP, Grandt J, Thing M, Hetland LE, Rashu EB, Jensen A-SH, et al. Circulating and hepatic levels of Growth Differentiation Factor 15 in patients with metabolic dysfunction-associated steatotic liver disease. Hepatol Res. 2025;55:492\u2013504. https:\/\/doi.org\/10.1111\/hepr.14148.","journal-title":"Hepatol Res"},{"key":"3243_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41387-021-00170-3","volume":"11","author":"J Bilson","year":"2021","unstructured":"Bilson J, Scorletti E, Bindels LB, Afolabi PR, Targher G, Calder PC, et al. Growth differentiation factor-15 and the association between type 2 diabetes and liver fibrosis in NAFLD. Nutr Diabetes. 2021;11:32. https:\/\/doi.org\/10.1038\/s41387-021-00170-3.","journal-title":"Nutr Diabetes"},{"key":"3243_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-026-68713-9","volume":"17","author":"H Tang","year":"2026","unstructured":"Tang H, Zhang X, Huang J, Chen X, Hong J, Lin H, et al. Sugar rationing during the first 1000 days of life and lifelong risk of heart failure. Nat Commun. 2026;17:1894. https:\/\/doi.org\/10.1038\/s41467-026-68713-9.","journal-title":"Nat Commun"},{"key":"3243_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnha.2025.100520","volume":"29","author":"H Tang","year":"2025","unstructured":"Tang H, Zhang X, Luo N, Huang J, Yang Q, Lin H, et al. Temporal trends in the Planetary Health Diet Index and its association with cardiovascular, kidney, and metabolic diseases: a comprehensive analysis from global and individual perspectives. J Nutr Health Aging. 2025;29:100520. https:\/\/doi.org\/10.1016\/j.jnha.2025.100520.","journal-title":"J Nutr Health Aging"},{"key":"3243_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02842-1","volume":"24","author":"K Liu","year":"2025","unstructured":"Liu K, Hu J, Huang Y, He D, Zhang J. Triglyceride-glucose-related indices and risk of cardiovascular disease and mortality in individuals with Cardiovascular-Kidney-Metabolic (CKM) Syndrome stages 0-3: a prospective cohort study of 282,920 participants in the UK Biobank. Cardiovasc Diabetol. 2025;24:277. https:\/\/doi.org\/10.1186\/s12933-025-02842-1.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR12","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun BB, Chiou J, Traylor M, Benner C, Hsu Y-H, Richardson TG, et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature. 2023;622:329\u201338. https:\/\/doi.org\/10.1038\/s41586-023-06592-6.","journal-title":"Nature"},{"key":"3243_CR13","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.cell.2024.10.045","volume":"188","author":"Y-T Deng","year":"2025","unstructured":"Deng Y-T, You J, He Y, Zhang Y, Li H-Y, Wu X-R, et al. Atlas of the plasma proteome in health and disease in 53,026 adults. Cell. 2025;188:253-271.e7. https:\/\/doi.org\/10.1016\/j.cell.2024.10.045.","journal-title":"Cell"},{"key":"3243_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-06375-9","volume":"23","author":"H Tang","year":"2025","unstructured":"Tang H, Huang J, Lin H, Zhang X, Yang Q, Luo N, et al. The global burden and biomarkers of cardiovascular disease attributable to ambient particulate matter pollution. J Transl Med. 2025;23:359. https:\/\/doi.org\/10.1186\/s12967-025-06375-9.","journal-title":"J Transl Med"},{"key":"3243_CR15","doi-asserted-by":"publisher","DOI":"10.59717\/j.xinn-med.2026.100197","author":"G Feng","year":"2026","unstructured":"Feng G, Wang H, Zhang T, Wang L, Huang L, Wei Y, et al. A Chinese Lunar New Year countdown to trustworthy medical research: eight traditions, eight statistical checkpoints. Time. 2026. https:\/\/doi.org\/10.59717\/j.xinn-med.2026.100197.","journal-title":"Time"},{"key":"3243_CR16","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.jhep.2024.09.033","volume":"82","author":"S Ran","year":"2025","unstructured":"Ran S, Zhang J, Tian F, Qian ZM, Wei S, Wang Y, et al. Association of metabolic signatures of air pollution with MASLD: observational and Mendelian randomization study. J Hepatol. 2025;82:560\u201370. https:\/\/doi.org\/10.1016\/j.jhep.2024.09.033.","journal-title":"J Hepatol"},{"key":"3243_CR17","doi-asserted-by":"publisher","first-page":"e697","DOI":"10.1212\/WNL.0000000000009924","volume":"95","author":"K Rannikm\u00e4e","year":"2020","unstructured":"Rannikm\u00e4e K, Ngoh K, Bush K, Al-Shahi Salman R, Doubal F, Flaig R, et al. Accuracy of identifying incident stroke cases from linked health care data in UK Biobank. Neurology. 2020;95:e697-707. https:\/\/doi.org\/10.1212\/WNL.0000000000009924.","journal-title":"Neurology"},{"key":"3243_CR18","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1475-6773.2012.01440.x","volume":"48","author":"A Metcalfe","year":"2013","unstructured":"Metcalfe A, Neudam A, Forde S, Liu M, Drosler S, Quan H, et al. Case definitions for acute myocardial infarction in administrative databases and their impact on in-hospital mortality rates. Health Serv Res. 2013;48:290\u2013318. https:\/\/doi.org\/10.1111\/j.1475-6773.2012.01440.x.","journal-title":"Health Serv Res"},{"key":"3243_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2020-000572","volume":"8","author":"KL Hayward","year":"2021","unstructured":"Hayward KL, Johnson AL, Horsfall LU, Moser C, Valery PC, Powell EE. Detecting non-alcoholic fatty liver disease and risk factors in health databases: accuracy and limitations of the ICD-10-AM. BMJ Open Gastroenterol. 2021;8:e000572. https:\/\/doi.org\/10.1136\/bmjgast-2020-000572.","journal-title":"BMJ Open Gastroenterol"},{"key":"3243_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g14","volume":"348","author":"VWV Jaddoe","year":"2014","unstructured":"Jaddoe VWV, de Jonge LL, Hofman A, Franco OH, Steegers EAP, Gaillard R. First trimester fetal growth restriction and cardiovascular risk factors in school age children: population based cohort study. BMJ. 2014;348:g14. https:\/\/doi.org\/10.1136\/bmj.g14.","journal-title":"BMJ"},{"key":"3243_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jnutbio.2024.109673","volume":"131","author":"Y Chen","year":"2024","unstructured":"Chen Y, Tang H, Luo N, Liang X, Yang P, Zhang X, et al. Association between flavonoid intake and rheumatoid arthritis among US adults. J Nutr Biochem. 2024;131:109673. https:\/\/doi.org\/10.1016\/j.jnutbio.2024.109673.","journal-title":"J Nutr Biochem"},{"key":"3243_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03084-5","volume":"25","author":"S-S Han","year":"2026","unstructured":"Han S-S, Liu Q, Zeng Z-M, Li Y, Li P-W, Cheng F-X, et al. Association of various insulin resistance surrogate indices with aging acceleration and future risk of cardiovascular disease in individuals with cardiovascular-kidney-metabolic syndrome stages 0-3: insights from CHARLS 2011-2020 data. Cardiovasc Diabetol. 2026;25:77. https:\/\/doi.org\/10.1186\/s12933-026-03084-5.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR23","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaf937","author":"B Kurt","year":"2025","unstructured":"Kurt B, Reugels M, Schneider KM, Spiesshoefer J, Milzi A, Gombert A, et al. C-reactive protein and cardiovascular risk in the general population. Eur Heart J. 2025. https:\/\/doi.org\/10.1093\/eurheartj\/ehaf937.","journal-title":"Eur Heart J"},{"key":"3243_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/bioinformatics\/btr597","volume":"28","author":"DJ Stekhoven","year":"2012","unstructured":"Stekhoven DJ, B\u00fchlmann P. MissForest\u2014non-parametric missing value imputation for mixed-type data. Bioinformatics. 2012;28:112\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btr597.","journal-title":"Bioinformatics"},{"key":"3243_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02721-9","volume":"24","author":"P Qin","year":"2025","unstructured":"Qin P, Ho FK, Celis-Morales CA, Pell JP. Association between systemic inflammation biomarkers and incident cardiovascular disease in 423,701 individuals: evidence from the UK biobank cohort. Cardiovasc Diabetol. 2025;24:162. https:\/\/doi.org\/10.1186\/s12933-025-02721-9.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03171-7","author":"J Wang","year":"2026","unstructured":"Wang J, Tu G, Tao Q, Li R, Zhai H, Hong S, et al. The prognostic significance of cholesterol, high-density lipoprotein and glucose (CHG) index in evaluating all-cause mortality risk in metabolic dysfunction-associated steatotic liver disease (MASLD) individuals: evidence from two cohort studies. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03171-7.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR27","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.035371","volume":"13","author":"X Liu","year":"2024","unstructured":"Liu X, Zhang H-J, Fang C-C, Li L, Lai Z-Q, Liang N-P, et al. Association between noninvasive liver fibrosis scores and heart failure in a general population. J Am Heart Assoc. 2024;13:e035371. https:\/\/doi.org\/10.1161\/JAHA.123.035371.","journal-title":"J Am Heart Assoc"},{"key":"3243_CR28","doi-asserted-by":"publisher","first-page":"2389","DOI":"10.1002\/sim.2712","volume":"26","author":"H Putter","year":"2007","unstructured":"Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389\u2013430. https:\/\/doi.org\/10.1002\/sim.2712.","journal-title":"Stat Med"},{"key":"3243_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02693-w","volume":"24","author":"H Tang","year":"2025","unstructured":"Tang H, Huang J, Zhang X, Chen X, Yang Q, Luo N, et al. Association between triglyceride glucose-body mass index and the trajectory of cardio-renal-metabolic multimorbidity: insights from multi-state modelling. Cardiovasc Diabetol. 2025;24:133. https:\/\/doi.org\/10.1186\/s12933-025-02693-w.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4414","author":"S Sabia","year":"2019","unstructured":"Sabia S, Fayosse A, Dumurgier J, Schnitzler A, Empana J-P, Ebmeier KP, et al. Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study. BMJ. 2019. https:\/\/doi.org\/10.1136\/bmj.l4414.","journal-title":"BMJ"},{"key":"3243_CR31","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/s41551-018-0304-0","volume":"2","author":"SM Lundberg","year":"2018","unstructured":"Lundberg SM, Nair B, Vavilala MS, Horibe M, Eisses MJ, Adams T, et al. Explainable machine-learning predictions for the prevention of hypoxaemia during surgery. Nat Biomed Eng. 2018;2:749\u201360. https:\/\/doi.org\/10.1038\/s41551-018-0304-0.","journal-title":"Nat Biomed Eng"},{"key":"3243_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btad723","volume":"39","author":"M Spytek","year":"2023","unstructured":"Spytek M, Krzyzi\u0144ski M, Langbein SH, Baniecki H, Wright MN, Biecek P. Survex: an R package for explaining machine learning survival models. Bioinformatics. 2023;39:btad723. https:\/\/doi.org\/10.1093\/bioinformatics\/btad723.","journal-title":"Bioinformatics"},{"key":"3243_CR33","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","volume":"42","author":"SCORE2 working group","year":"2021","unstructured":"SCORE2 working group, ESC Cardiovascular risk collaboration. SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe. Eur Heart J. 2021;42:2439\u201354. https:\/\/doi.org\/10.1093\/eurheartj\/ehab309.","journal-title":"Eur Heart J"},{"key":"3243_CR34","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D\u2019Agostino RB, Steyerberg EW. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med. 2011;30:11\u201321. https:\/\/doi.org\/10.1002\/sim.4085.","journal-title":"Stat Med"},{"key":"3243_CR35","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1002\/sim.5647","volume":"32","author":"H Uno","year":"2013","unstructured":"Uno H, Tian L, Cai T, Kohane IS, Wei LJ. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32:2430\u201342. https:\/\/doi.org\/10.1002\/sim.5647.","journal-title":"Stat Med"},{"key":"3243_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02662-3","volume":"24","author":"J Hong","year":"2025","unstructured":"Hong J, Zhang R, Tang H, Wu S, Chen Y, Tan X. Comparison of triglyceride glucose index and modified triglyceride glucose indices in predicting cardiovascular diseases incidence among populations with cardiovascular-kidney-metabolic syndrome stages 0-3: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24:98. https:\/\/doi.org\/10.1186\/s12933-025-02662-3.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR37","doi-asserted-by":"publisher","first-page":"495","DOI":"10.12182\/20250360503","volume":"56","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Wang L, Li J, Guo B, Zhang J, Guo X, et al. Association between surrogate markers of insulin resistance and incident cardiovascular disease in a population with stages 0\u20133 cardiovascular-kidney-metabolic syndrome: a prospective cohort study. Sichuan Da Xue Xue Bao Yi Xue Ban. 2025;56:495\u2013505. https:\/\/doi.org\/10.12182\/20250360503.","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"3243_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02689-6","volume":"24","author":"M-Y Tan","year":"2025","unstructured":"Tan M-Y, Zhang Y-J, Zhu S-X, Wu S, Zhang P, Gao M. The prognostic significance of stress hyperglycemia ratio in evaluating all-cause and cardiovascular mortality risk among individuals across stages 0-3 of cardiovascular-kidney-metabolic syndrome: evidence from two cohort studies. Cardiovasc Diabetol. 2025;24:137. https:\/\/doi.org\/10.1186\/s12933-025-02689-6.","journal-title":"Cardiovasc Diabetol"},{"issue":"25","key":"3243_CR39","doi-asserted-by":"publisher","first-page":"10429","DOI":"10.1016\/j.jacc.2025.12.015","volume":"S0735\u20131097","author":"F Zannad","year":"2026","unstructured":"Zannad F, Khan MS, Bansal N, B\u00f6hm M, Francque SM, Girerd N, et al. MASLD, MASH, and the CKM spectrum: a roadmap for multiorgan clinical trial design. J Am Coll Cardiol. 2026;S0735\u20131097(25):10429\u201334. https:\/\/doi.org\/10.1016\/j.jacc.2025.12.015.","journal-title":"J Am Coll Cardiol"},{"key":"3243_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001645","author":"X-D Zhou","year":"2025","unstructured":"Zhou X-D, Chen Q-F, Fan Q-Y, Kim SU, Yip TC-F, Petta S, et al. Cardiovascular-kidney-metabolic syndrome and the risk of liver fibrosis progression and liver-related events in MASLD. Hepatology. 2025. https:\/\/doi.org\/10.1097\/HEP.0000000000001645.","journal-title":"Hepatology"},{"key":"3243_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s43856-025-01195-w","volume":"5","author":"Q Chen","year":"2025","unstructured":"Chen Q, Zhu Y, Gao J, Ni W, Liu S, Rui F, et al. Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD). Commun Med. 2025;5:492. https:\/\/doi.org\/10.1038\/s43856-025-01195-w.","journal-title":"Commun Med"},{"key":"3243_CR42","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.cgh.2025.06.036","volume":"24","author":"LA van Kleef","year":"2026","unstructured":"van Kleef LA, Strandberg R, Pustjens J, Hammar N, Janssen HLA, Hagstr\u00f6m H, et al. FIB-4-based referral pathways have suboptimal accuracy to identify increased liver stiffness and incident advanced liver disease. Clin Gastroenterol Hepatol. 2026;24:733\u201342. https:\/\/doi.org\/10.1016\/j.cgh.2025.06.036.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3243_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24:12. https:\/\/doi.org\/10.1186\/s12933-024-02572-w.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-025-02716-6","volume":"24","author":"Z Song","year":"2025","unstructured":"Song Z, Miao X, Liu S, Hu M, Xie X, Sun Y, et al. Associations between cardiometabolic indices and the onset of metabolic dysfunction-associated steatotic liver disease as well as its progression to liver fibrosis: a cohort study. Cardiovasc Diabetol. 2025;24:154. https:\/\/doi.org\/10.1186\/s12933-025-02716-6.","journal-title":"Cardiovasc Diabetol"},{"key":"3243_CR45","doi-asserted-by":"publisher","DOI":"10.2174\/011573403X332671241121063641","volume":"21","author":"K Tiwari","year":"2025","unstructured":"Tiwari K, Saravanan A, Anil A, Tiwari VK, Shamim MA, Singh S, et al. Molecular and functional significance of Growth Differentiation Factor-15: a review on Cardiovascular-Kidney-Metabolic biomarker. Curr Cardiol Rev. 2025;21:e1573403X332671. https:\/\/doi.org\/10.2174\/011573403X332671241121063641.","journal-title":"Curr Cardiol Rev"},{"key":"3243_CR46","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1373\/clinchem.2016.255174","volume":"63","author":"KC Wollert","year":"2017","unstructured":"Wollert KC, Kempf T, Wallentin L. Growth Differentiation Factor 15 as a biomarker in cardiovascular disease. Clin Chem. 2017;63:140\u201351. https:\/\/doi.org\/10.1373\/clinchem.2016.255174.","journal-title":"Clin Chem"},{"key":"3243_CR47","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/nm.4393","volume":"23","author":"PJ Emmerson","year":"2017","unstructured":"Emmerson PJ, Wang F, Du Y, Liu Q, Pickard RT, Gonciarz MD, et al. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL. Nat Med. 2017;23:1215\u20139. https:\/\/doi.org\/10.1038\/nm.4393.","journal-title":"Nat Med"},{"key":"3243_CR48","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1038\/nm.4394","volume":"23","author":"L Yang","year":"2017","unstructured":"Yang L, Chang C-C, Sun Z, Madsen D, Zhu H, Padkj\u00e6r SB, et al. GFRAL is the receptor for GDF15 and is required for the anti-obesity effects of the ligand. Nat Med. 2017;23:1158\u201366. https:\/\/doi.org\/10.1038\/nm.4394.","journal-title":"Nat Med"},{"key":"3243_CR49","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-023-06249-4","volume":"619","author":"D Wang","year":"2023","unstructured":"Wang D, Townsend LK, DesOrmeaux GJ, Frangos SM, Batchuluun B, Dumont L, et al. GDF15 promotes weight loss by enhancing energy expenditure in muscle. Nature. 2023;619:143\u201350. https:\/\/doi.org\/10.1038\/s41586-023-06249-4.","journal-title":"Nature"},{"key":"3243_CR50","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1093\/eurheartj\/ehn600","volume":"30","author":"SQ Khan","year":"2009","unstructured":"Khan SQ, Ng K, Dhillon O, Kelly D, Quinn P, Squire IB, et al. Growth differentiation factor-15 as a prognostic marker in patients with acute myocardial infarction. Eur Heart J. 2009;30:1057\u201365. https:\/\/doi.org\/10.1093\/eurheartj\/ehn600.","journal-title":"Eur Heart J"},{"key":"3243_CR51","doi-asserted-by":"publisher","first-page":"D1692","DOI":"10.1093\/nar\/gkaf1154","volume":"54","author":"Y Zhang","year":"2026","unstructured":"Zhang Y, Zhou Y, Xu H, Jiang W, Li B, Lai D, et al. Therapeutic target database 2026: facilitating targeted therapies and precision medicine. Nucleic Acids Res. 2026;54:D1692\u2013701. https:\/\/doi.org\/10.1093\/nar\/gkaf1154.","journal-title":"Nucleic Acids Res"},{"key":"3243_CR52","doi-asserted-by":"publisher","first-page":"2291","DOI":"10.1056\/NEJMoa2409515","volume":"391","author":"JD Groarke","year":"2024","unstructured":"Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, et al. Ponsegromab for the treatment of cancer cachexia. N Engl J Med. 2024;391:2291\u2013303. https:\/\/doi.org\/10.1056\/NEJMoa2409515.","journal-title":"N Engl J Med"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03243-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03243-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T23:31:42Z","timestamp":1787095902000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03243-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3243"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03243-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"11 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The UK Biobank was approved by the North West Multicenter Research Ethics Committee, with all participants providing written informed consent. Ethical approval and informed consent were waived as the UK Biobank data is publicly available and does not include identifiable information.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"242"}}